Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:steroid
go back to main search page
Accession:XCO:0000091 term browser browse the term
Definition:Any condition in which the main influencing factor is a naturally occurring compound or related synthetic analog with a molecular structure based on the cyclopenta[a]phenanthrene carbon skeleton, that is, a phenanthrene, to the a side of which a three-carbon fragment is fused. According to the definition at the Chemical Entities of Biological Importance (ChEBI) database, 'By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred' which expands the class to include molecules based on but not containing the cannonical arrangement of four fused cycloalkane rings.
Synonyms:xref: CHEBI:35341


show annotations for term's descendants           Sort by:
17 beta-estradiol term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Anxrr39 Anxiety related response QTL 39 IDA RGD PMID:21516450 RGD:6218999
Q Anxrr40 Anxiety related response QTL 40 IDA RGD PMID:21516450 RGD:6218999 NCBI chr 4:62,753,847...107,753,847 JBrowse link
Q Anxrr42 Anxiety related response QTL 42 IDA RGD PMID:21516450 RGD:6218999 NCBI chr 4:144,639,524...182,687,754 JBrowse link
Q Anxrr47 Anxiety related response QTL 47 IDA RGD PMID:21516450 RGD:6218999 NCBI chr 4:10,084,089...55,084,089 JBrowse link
Q Anxrr49 Anxiety related response QTL 49 IDA RGD PMID:21516450 RGD:6218999 NCBI chr 4:62,753,847...107,753,847 JBrowse link
Q Anxrr50 Anxiety related response QTL 50 IDA RGD PMID:21516450 RGD:6218999
Q Anxrr51 Anxiety related response QTL 51 IDA RGD PMID:21516450 RGD:6218999 NCBI chr 4:124,778,595...169,778,595 JBrowse link
Q Emca1 Estrogen-induced mammary cancer QTL 1 IDA RGD PMID:15611180 RGD:1358124 NCBI chr 5:99,216,724...148,607,142 JBrowse link
Q Emca10 Estrogen-induced mammary cancer QTL 10 IDA RGD PMID:18420736 RGD:2292503 NCBI chr 6:16,536,140...61,536,140 JBrowse link
Q Emca11 Estrogen-induced mammary cancer QTL 11 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:99,753,548...113,061,097 JBrowse link
Q Emca12 Estrogen-induced mammary cancer QTL 12 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:124,160,767...133,749,643 JBrowse link
Q Emca13 Estrogen-induced mammary cancer QTL 13 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:9,823,266...99,753,708 JBrowse link
Q Emca2 Estrogen-induced mammary cancer QTL 2 IDA RGD PMID:15611180 RGD:1358124 NCBI chr18:18,007,599...63,571,040 JBrowse link
Q Emca4 Estrogen-induced mammary cancer QTL 4 IDA 27.5mg crystalline implant RGD PMID:16885383 RGD:1642522 NCBI chr 7:62,004,452...101,773,158 JBrowse link
Q Emca5 Estrogen-induced mammary cancer QTL 5 IDA 27.5mg crystalline implant RGD PMID:16885383 RGD:1642522 NCBI chr 3:43,827,364...169,034,231 JBrowse link
Q Emca6 Estrogen-induced mammary cancer QTL 6 IDA 27.5mg/ml crystalline implant RGD PMID:16885383 RGD:1642522 NCBI chr 4:44,463,720...155,883,716 JBrowse link
Q Emca7 Estrogen-induced mammary cancer QTL 7 IDA 27.5mg/ml crystalline implant RGD PMID:16885383 RGD:1642522 NCBI chr 6:15,107,216...107,351,382 JBrowse link
Q Emca8 Estrogen-induced mammary cancer QTL 8 IDA 27.5mg/ml crystalline implant RGD PMID:16885383 RGD:1642522 NCBI chr 5:50,328,551...141,643,988 JBrowse link
Q Ept15 Estrogen-induced pituitary tumorigenesis QTL 15 IDA RGD PMID:2292503 RGD:7175546 NCBI chr 6:9,843,312...20,338,915 JBrowse link
Q Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 IDA RGD PMID:2292503 RGD:7175546 NCBI chr 3:47,233,430...110,362,260 JBrowse link
Q Ept17 Estrogen-induced pituitary tumorigenesis QTL 17 IDA RGD PMID:2292503 RGD:7175546 NCBI chr 3:6,537,645...10,778,823 JBrowse link
Q Ept18 Estrogen-induced pituitary tumorigenesis QTL 18 IDA RGD PMID:2292503 RGD:7175546 NCBI chr10:73,453,136...96,120,911 JBrowse link
Q Ept5 Estrogen-induced pituitary tumorigenesis QTL 5 IDA 27.5mg/ml crystalline implant RGD PMID:17876666 RGD:1642526 NCBI chr 4:83,428,419...177,635,233 JBrowse link
Q Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 IDA 27.5mg/ml crystalline implant RGD PMID:17876666 RGD:1642526 NCBI chr 7:62,004,452...101,773,158 JBrowse link
Q Eutr1 Estrogen induced uterine response QTL 1 IDA RGD PMID:16284801 RGD:1559292 NCBI chr 5:2,138,965...166,875,058 JBrowse link
deoxycorticosterone acetate term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Rends1 Renal damage susceptibility QTL 1 IDA RGD PMID:10454439 RGD:632218 NCBI chr 1:169,537,671...214,537,671 JBrowse link
dexamethasone term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Bw74 Body weight QTL 74 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 3:53,184,593...115,665,732 JBrowse link
Q Bw75 Body weight QTL 75 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 7:15,795,565...38,073,970 JBrowse link
Q Bw76 Body weight QTL 76 IDA RGD PMID:15728334 RGD:1580752 NCBI chr17:9,201,365...23,653,323 JBrowse link
Q Bw77 Body weight QTL 77 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 3:53,184,593...64,655,484 JBrowse link
Q Bw78 Body weight QTL 78 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 5:119,085,612...128,034,027 JBrowse link
Q Bw79 Body weight QTL 79 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:28,030,665...82,262,678 JBrowse link
Q Cm60 Cardiac mass QTL 60 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 2:57,605,612...76,539,510 JBrowse link
Q Epfw1 Epididymal fat weight QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 3:53,184,593...115,665,732 JBrowse link
Q Epfw2 Epididymal fat weight QTL 2 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 8:31,737,729...76,737,729 JBrowse link
Q Epfw3 Epididymal fat weight QTL 3 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:28,030,665...82,262,678 JBrowse link
Q Epfw4 Epididymal fat weight QTL 4 IDA RGD PMID:15728334 RGD:1580752 NCBI chr17:9,201,365...23,653,323 JBrowse link
Q Gluco24 Glucose level QTL 24 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:5,530,756...50,530,756 JBrowse link
Q Gluco25 Glucose level QTL 25 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 4:85,253,748...148,090,731 JBrowse link
Q Gluco26 Glucose level QTL 26 IDA RGD PMID:15728334 RGD:1580752 NCBI chr14:73,415,323...95,876,975 JBrowse link
Q Gluco27 Glucose level QTL 27 IDA RGD PMID:15728334 RGD:1580752 NCBI chr14:73,415,323...92,554,092 JBrowse link
Q Gluco28 Glucose level QTL 28 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:28,030,665...82,262,678 JBrowse link
Q Gluco29 Glucose level QTL 29 IDA RGD PMID:15728334 RGD:1580752 NCBI chr14:73,415,323...92,554,092 JBrowse link
Q Gluco30 Glucose level QTL 30 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:28,030,665...82,262,678 JBrowse link
Q Insul10 Insulin level QTL 10 IDA RGD PMID:15728334 RGD:1580752
Q Insul6 Insulin level QTL 6 IDA RGD PMID:15728334 RGD:1580752
Q Insul7 Insulin level QTL 7 IDA RGD PMID:15728334 RGD:1580752
Q Insul8 Insulin level QTL 8 IDA RGD PMID:15728334 RGD:1580752 NCBI chr16:1...26,727,669 JBrowse link
Q Insul9 Insulin level QTL 9 IDA RGD PMID:15728334 RGD:1580752
Q Kidm30 Kidney mass QTL 30 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 3:64,655,305...115,665,732 JBrowse link
Q Kidm31 Kidney mass QTL 31 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 8:54,237,644...85,365,202 JBrowse link
Q Kidm32 Kidney mass QTL 32 IDA RGD PMID:15728334 RGD:1580752 NCBI chr17:9,201,365...23,653,323 JBrowse link
Q Kidm33 Kidney mass QTL 33 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 1:188,377,360...224,054,420 JBrowse link
Q Kidm34 Kidney mass QTL 34 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 4:148,090,542...168,069,246 JBrowse link
Q Livw1 Liver weight QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 1:155,422,851...172,949,803 JBrowse link
Q Livw2 Liver weight QTL 2 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 5:99,016,066...119,085,810 JBrowse link
Q Sffal1 Serum free fatty acids level QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 7:116,677,010...124,049,952 JBrowse link
Q Sffal2 Serum free fatty acids level QTL 2 IDA RGD PMID:15728334 RGD:1580752 NCBI chr14:92,553,886...95,876,975 JBrowse link
Q Stl20 Serum triglyceride level QTL 20 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 8:48,630,131...49,147,989 JBrowse link
Q Stl21 Serum triglyceride level QTL 21 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:28,030,665...82,262,678 JBrowse link
Q Sual1 Serum uric acid level QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 3:96,127,817...102,200,699 JBrowse link
diethylstilbestrol term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Edpm1 Estrogen-dependent pituitary mass QTL 1 IDA RGD PMID:9337394 RGD:61074 NCBI chr 2:35,134,841...88,029,593 JBrowse link
Q Edpm10 Estrogen-dependent pituitary mass QTL 10 IDA RGD PMID:9337394 RGD:61074
Q Edpm11 Estrogen-dependent pituitary mass QTL 11 IDA RGD PMID:11003699 RGD:629550 NCBI chr 9:1...43,718,459 JBrowse link
Q Edpm12 Estrogen-dependent pituitary mass QTL 12 IDA RGD PMID:11003699 RGD:629550 NCBI chr  X:2,927,898...47,927,898 JBrowse link
Q Edpm2 Estrogen-dependent pituitary mass QTL 2 IDA RGD PMID:9337394 RGD:61074 NCBI chr 2:76,539,322...202,447,032 JBrowse link
Q Edpm3 Estrogen-dependent pituitary mass QTL 3 IDA RGD PMID:9337394 RGD:61074 NCBI chr 3:53,184,692...89,878,207 JBrowse link
Q Edpm5 Estrogen-dependent pituitary mass QTL 5 IDA RGD PMID:9337394 RGD:61074 NCBI chr 5:68,984,307...104,251,008 JBrowse link
Q Edpm9 Estrogen-dependent pituitary mass QTL 9 IDA RGD PMID:9337394 RGD:61074 NCBI chr 9:63,869,687...108,869,687 JBrowse link
Q Ept1 Estrogen-induced pituitary tumorigenesis QTL 1 IDA RGD PMID:15687265 RGD:1334449 NCBI chr 6:9,843,312...20,338,915 JBrowse link
Q Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 IDA RGD PMID:15687265 RGD:1334449 NCBI chr 1:192,825,253...243,914,732 JBrowse link
Q Ept13 Estrogen-induced pituitary tumorigenesis QTL 13 IDA RGD PMID:15687265 RGD:1334449 NCBI chr 1:77,494,165...122,494,165 JBrowse link
Q Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 IDA RGD PMID:15687265 RGD:1334449 NCBI chr 3:47,233,430...110,362,260 JBrowse link
Q Ept6 Estrogen-induced pituitary tumorigenesis QTL 6 IDA RGD PMID:15687265 RGD:1334449 NCBI chr 3:6,537,645...10,778,823 JBrowse link
Q Ept9 Estrogen-induced pituitary tumorigenesis QTL 9 IDA RGD PMID:15687265 RGD:1334449 NCBI chr10:73,453,136...96,120,911 JBrowse link
Q Esta1 Estrogen-induced thymic atrophy QTL 1 IDA RGD PMID:16688534 RGD:1579780 NCBI chr10:21,329,805...61,345,413 JBrowse link
Q Esta2 Estrogen-induced thymic atrophy QTL 2 IDA RGD PMID:16688534 RGD:1579780 NCBI chr 2:189,599,258...226,936,289 JBrowse link
Q Esta3 Estrogen-induced thymic atrophy QTL 3 IDA RGD PMID:16688534 RGD:1579780 NCBI chr 2:136,916,935...189,599,348 JBrowse link
Q Esta4 Estrogen-induced thymic atrophy QTL 4 IDA RGD PMID:18420736 RGD:2292503 NCBI chr 3:47,233,211...147,415,807 JBrowse link
Q Eutr2 Estrogen induced uterine response QTL 2 IDA RGD PMID:16284802 RGD:1559291 NCBI chr 5:34,730,116...104,251,008 JBrowse link
Q Teswt1 Testicular weight QTL 1 IDA RGD PMID:16651691 RGD:1625009 NCBI chr 7:80,221,299...94,811,326 JBrowse link
Q Teswt2 Testicular weight QTL 2 IDA RGD PMID:16651691 RGD:1625009 NCBI chr 1:197,697,768...238,755,659 JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    chemical 1266
      chemical with specified structure 1131
        steroid 82
          MK-0773 0
          beta-Sitosterol 0
          dexamethasone + 35
          pregnenolone 16alpha-carbonitrile 0
          steroid hormone + 47
paths to the root